Home

Sprengstoff Zeitfolgen Norden melissa gkavogiani Dim Seehafen Genosse

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Myeloid phenotypes in severe COVID-19 predict secondary infection and  mortality: a pilot study | Annals of Intensive Care | Full Text
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study | Annals of Intensive Care | Full Text

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Myeloid phenotypes in severe COVID-19 predict secondary infection and  mortality: a pilot study | Annals of Intensive Care | Full Text
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study | Annals of Intensive Care | Full Text

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
Kinetics of antibody responses dictate COVID-19 outcome | medRxiv

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Top-Level Speakers - London Build 2022 - THE UK'S LEADING CONSTRUCTION &  DESIGN SHOW
Top-Level Speakers - London Build 2022 - THE UK'S LEADING CONSTRUCTION & DESIGN SHOW

Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
Kinetics of antibody responses dictate COVID-19 outcome | medRxiv

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Hydrogen sulfide dysregulates the immune response by suppressing central  carbon metabolism to promote tuberculosis | PNAS
Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis | PNAS

Issue: Cell
Issue: Cell

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Issue: Cell
Issue: Cell

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from  reinfection via epigenetic reprogramming of monocytes | PNAS
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes | PNAS

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Hydrogen sulfide dysregulates the immune response by suppressing central  carbon metabolism to promote tuberculosis | PNAS
Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis | PNAS

Hydrogen sulfide dysregulates the immune response by suppressing central  carbon metabolism to promote tuberculosis | PNAS
Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis | PNAS